DCU Alpha and Portal Innovations Announce Strategic Partnership to Launch a New Life Sciences and Deeptech Innovation Hub in Ireland

Dublin City University’s DCU Alpha and Portal Innovations from the USA.,have announced a strategic partnership to establish a new venture-building platform in Dublin, designed to support and scale indigenous Irish companies in the biotech, pharma, medtech, and deeptech sectors. This initiative comes at a crucial time for the life sciences industry in Ireland, as companies navigate an evolving global landscape marked by trade and tariff challenges.

The collaboration will see the development over time of a dedicated 20,000 sq ft life sciences and deeptech innovation facility within DCU Alpha, providing startups with the space and equipment needed to thrive. The new facility will combine fully equipped wet and dry labs, incubation space, accelerator programmes, and access to a dedicated seed fund. This initiative aims to bridge the gap between university-based research and commercially viable ventures, ensuring that cutting-edge discoveries make a tangible impact on both the economy and societal health.

A Catalyst for Innovation

Portal Innovations, a leading venture-building firm, specialises in supporting life sciences and deeptech entrepreneurs by providing them with seed capital, world-class infrastructure, and strategic mentorship. Through this partnership, Dublin City University’s Life Sciences Institute will extend its expertise and infrastructure to startups within the Portal Innovations ecosystem, granting them access to DCU’s vast research networks and Core Technologies facilities at the university’s Glasnevin campus.

A Thriving Innovation Cluster

The new Portal Innovations facility will be co-located within an already established deeptech ecosystem of pioneering companies already based at DCU Alpha, including Fire1, Deciphex, Dolmen Design, BlueBridge Technologies, Coroflo, Marama Labs, SCRI-IS, Pilot Photonics, HT Materials Science, WellAir, Taoglas, Keltech IoE, Eiratech Robotics, Ubotica, Enbio, Exergyn, and Endotronix, among others.

Ronan Cunningham, Director, DCU Invent, said:

“At DCU Alpha, we are committed to fostering an environment where deeptech and life sciences startups can thrive. This collaboration with Portal Innovations represents a major step forward in supporting indigenous innovation and ensuring that Ireland remains a competitive hub for scientific and technological advancements.”

Nancy Tyrrell, Director of Academic Partnerships at Portal Innovations, said:

“Ireland has a rich history of scientific excellence, and this partnership with DCU Alpha represents a unique opportunity to accelerate the commercialisation of groundbreaking research. By bringing our proven venture-building model to Dublin, we aim to provide life sciences and deeptech entrepreneurs with the critical resources, funding, and mentorship they need to succeed on a global scale.”